These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22035702)

  • 1. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
    Bini EJ; Kritz S; Brown LS; Robinson J; Calsyn D; Alderson D; Tracy K; McAuliffe P; Smith C; Rotrosen J
    J Subst Abuse Treat; 2012 Jun; 42(4):438-45. PubMed ID: 22035702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program.
    Felsen UR; Fishbein DA; Litwin AH
    J Addict Dis; 2010 Oct; 29(4):461-5. PubMed ID: 20924882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia.
    Winstock AR; Anderson CM; Sheridan J
    Med J Aust; 2006 Jun; 184(11):560-2. PubMed ID: 16768662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
    Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB
    Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
    Frimpong JA; D'Aunno T; Jiang L
    Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
    Astone JM; Strauss SM; Hagan H; Des Jarlais DC
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.
    Brown LS; Kritz S; Goldsmith RJ; Bini EJ; Robinson J; Alderson D; Rotrosen J
    Public Health Rep; 2007; 122(4):441-51. PubMed ID: 17639646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
    Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
    Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.
    Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q
    J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014.
    Ward JW
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):1-4. PubMed ID: 27168654
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection.
    Perumalswami PV; Bini EJ
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):145-55. PubMed ID: 16557186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in the drug-free and methadone treatment program response to Hepatitis C.
    Strauss SM; Astone J; Vassilev ZP; Des Jarlais DC; Hagan H
    J Subst Abuse Treat; 2003 Jun; 24(4):291-7. PubMed ID: 12867202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
    Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
    Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.